These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7522022)

  • 21. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.
    Darwish MA; Raouf TA; Rushdy P; Constantine NT; Rao MR; Edelman R
    Am J Trop Med Hyg; 1993 Oct; 49(4):440-7. PubMed ID: 7692754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
    Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
    J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.
    Chaudhary RK; MacLean C
    J Clin Microbiol; 1991 Oct; 29(10):2329-30. PubMed ID: 1719025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An algorithm for confirming screen reactivity in blood donors in enzyme immunoassays for antibodies to hepatitis C virus.
    Craske J; Paver WK; Farmer D
    J Immunol Methods; 1993 Apr; 160(2):227-35. PubMed ID: 7681460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
    León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
    Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological diagnosis of hepatitis C virus in patients with liver disease in Saudi Arabia. Evaluation of antibody determination by recombinant immunoblot assays in relation to RNA detection by polymerase chain reaction.
    Al-Ahdal MN; Kessie G
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):69-73. PubMed ID: 9147007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
    Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
    Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
    Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S
    Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New-generation RIBA hepatitis C strip immunoblot assays.
    Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
    Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
    Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
    Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report.
    Vrielink H; van der Poel CL; Reesink HW; Zaaijer HL; Lelie PN
    Vox Sang; 1995; 68(1):55-6. PubMed ID: 7536990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus among blood donors: follow-up study.
    Alonso C; Pedroso ML; de Sanjosé S; Montcharmont P; Chèvre JM; Boucaud MJ; Lambert V; Cortey ML; Trépo C
    Transfusion; 1994 Jun; 34(6):527-30. PubMed ID: 8023395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype.
    Dow BC; Munro H; Buchanan I; Follett EA; Davidson F; Yap PL; Simmonds P
    Transfusion; 1996 Jun; 36(6):547-51. PubMed ID: 8669088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
    Hyland CA; Kearns S; Young IF; Battistutta D; Morgan CL
    Transfus Med; 1992 Sep; 2(3):207-13. PubMed ID: 1285010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
    de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
    J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction.
    Marcellin P; Martinot-Peignoux M; Gabriel F; Branger M; Degott C; Elias A; Xu LZ; Larzul D; Erlinger S; Benhamou JP
    J Hepatol; 1993 Aug; 19(1):167-70. PubMed ID: 7507951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
    Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
    N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.